TrialJournal of experimental & clinical cancer research : CR2012

Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation.

Antonello Vidiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.